Novel PAradigm to Improve Inflammatory Burden in ESRD (rePAIR): A Pilot and Feasibility Randomized Controlled Trial
Status: | Recruiting |
---|---|
Conditions: | Renal Impairment / Chronic Kidney Disease, Renal Impairment / Chronic Kidney Disease, Dental |
Therapuetic Areas: | Dental / Maxillofacial Surgery, Nephrology / Urology |
Healthy: | No |
Age Range: | 21 - Any |
Updated: | 9/27/2018 |
Start Date: | November 7, 2017 |
End Date: | April 2019 |
Contact: | Megyn Clement, CCRP |
Email: | mclement@uchc.edu |
Phone: | 860-679-4995 |
Pilot and Feasibility Clinical Research Grants in Kidney or Urologic Diseases (R21)
The goal of this project is to assess repeated and ongoing oral care and the way it may
affect inflammation and quality of life in hemodialysis patients. Two treatment groups will
be compared:
- 1) ongoing and repeated gum disease therapy including deep tooth cleaning followed by
multiple appointments of maintenance
- 2) single session of gum disease therapy with only one session of deep tooth cleaning
Samples of blood will be obtained for study to examine the changes of inflammatory
substances in the blood as a result of the two different gum disease treatments. Also, a
14-question survey will be discussed with you to assess oral health related quality of
life (OHIP-14) and the way it is affected by oral care.
For this project, four dialysis centers will be randomly assigned to either of the treatment
groups #1 or #2 prior to your enrollment. For this purpose, there are two distinct consent
forms explaining the visits, procedures and risks of the two treatment groups #1 or #2. As a
result, all participants in the same dialysis center will belong to the same treatment group
(either #1 or #2) and presented with the corresponding consent form.
This dialysis center has been randomized to treatment group # 1; therefore you will receive
ongoing and repeated gum disease therapy including deep tooth cleaning followed by multiple
appointments of maintenance.
affect inflammation and quality of life in hemodialysis patients. Two treatment groups will
be compared:
- 1) ongoing and repeated gum disease therapy including deep tooth cleaning followed by
multiple appointments of maintenance
- 2) single session of gum disease therapy with only one session of deep tooth cleaning
Samples of blood will be obtained for study to examine the changes of inflammatory
substances in the blood as a result of the two different gum disease treatments. Also, a
14-question survey will be discussed with you to assess oral health related quality of
life (OHIP-14) and the way it is affected by oral care.
For this project, four dialysis centers will be randomly assigned to either of the treatment
groups #1 or #2 prior to your enrollment. For this purpose, there are two distinct consent
forms explaining the visits, procedures and risks of the two treatment groups #1 or #2. As a
result, all participants in the same dialysis center will belong to the same treatment group
(either #1 or #2) and presented with the corresponding consent form.
This dialysis center has been randomized to treatment group # 1; therefore you will receive
ongoing and repeated gum disease therapy including deep tooth cleaning followed by multiple
appointments of maintenance.
Inclusion Criteria:
- Patient must be referred by nephrologist
- Patient must be diagnosed with ESRD and on Hemodialysis
- life expectancy more than one year
- at least 21 years of age
- 12 or more teeth
- must meet the Periodontal diagnosis criteria (The diagnosis of periodontitis is based
on the definition of moderate periodontitis with at least 2 sites with CAL≥4mm or at
least 2 sites with PD≥5mm not on the same tooth (Page and Eke 2007).)
Exclusion Criteria:
- Anticipating a kidney transplant
- AIDS
- Active malignancy
- Poor adherence to hemodialysis
- Dementia
- Currently prescribed anti-inflammatory medication
- Temporary catheter for dialysis access
- Gum disease treatment within the last year
We found this trial at
1
site
263 Farmington Ave
Farmington, Connecticut 06030
Farmington, Connecticut 06030
(860) 679-2000
Principal Investigator: Effie Ioannidou, DDS, MDS
Phone: 860-679-4995
University of Connecticut Health Center UConn Health is a vibrant, integrated academic medical center that...
Click here to add this to my saved trials